Biobanks Market by Component (Consumables, Equipment, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Application - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the biobanks market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[198 Pages Report] The Biobanks Market size was estimated at USD 67.81 billion in 2023 and expected to reach USD 75.75 billion in 2024, at a CAGR 11.80% to reach USD 148.10 billion by 2030.

The biobank market encompasses collecting, processing, storing, and distributing biological materials such as tissues, blood, plasma, DNA, and other biomolecules obtained from humans, animals, or plants. These biobanks are crucial in supporting research into disease mechanisms, drug discovery, and personalized medicine. They act as libraries for the medical research community, providing access to high-quality, well-characterized, and ethically sourced biological samples and associated data. Biobanks serve various end-use applications, including basic and clinical research, therapeutic target identification, and diagnostics development. The primary end-users of biobanks include pharmaceutical and biotechnology firms, academic and research institutions, and contract research organizations (CROs). Technological progress in bio-preservation and data handling, increased investment in medical research, a higher incidence of chronic illnesses necessitating new studies, and a robust ethical framework that builds trust in biobanking practices drive the market growth. Additionally, partnerships between key players are solidifying the biobank infrastructure. Despite the growth, ethical dilemmas, standardization issues, financial constraints, and logistical hurdles pose challenges. Nonetheless, there are abundant opportunities for expansion, particularly through innovations such as artificial intelligence, increased genomic research demands, and untapped emerging markets. To encourage expansion, the players need to focus on enhancing preservation techniques, improving data systems, standardizing biobanking processes, exploring new financial models, and engaging with the public to foster trust. Strategic investments in these areas are expected to revitalize biobanking, benefiting medical research globally.
Regional Insights

Biobanks are essential in advancing medical research and healthcare on a global scale. The United States leads with a robust research infrastructure, strong governmental backing, and significant patent activity, while Canada benefits from supportive healthcare policies and national biobanking networks. In Europe, countries such as Germany and Sweden are pivotal, driven by collaborative projects and EU regulations focused on ethical standards. The Middle East, including the UAE and Saudi Arabia, is investing in biobanks to enhance public health and personalized medicine. South Africa spearheads efforts in Africa, focusing on local disease research. China’s biobanking sector is rapidly growing, spurred by government initiatives and consumer demand for genetic testing. Japan's emphasis on regenerative medicine and aging populations propels its market, while India's biobank landscape is expanding through strategic investments and rising interest in genetic research. Latin American countries such as Brazil and Mexico are advancing biobank projects to tackle local health issues, whereas ASEAN nations such as Singapore and Malaysia benefit from government backing and international collaborations. The Asia-Pacific region addresses diverse needs, from Japan’s aging population to India’s public health advancements, with a focus on precision medicine and genetic disease awareness. The Americas, led by the U.S. and Canada, exhibit strong research activities and consumer engagement. The EMEA region, encompassing Europe, the Middle East, and Africa, balances ethical considerations and regulatory frameworks to enhance its market.

The biobanking landscape is predicted to be vibrant, underpinned by developments in cryopreservation, AI-driven disease prediction models, and blockchain for secure data management. Increased governmental and private investments aim to expand biobank capacities, foster public-private partnerships, and drive the commercialization of new biobank-driven therapies. Developed nations foresee potential in advanced research and technological integration despite challenges related to data privacy and operational costs. Emerging countries such as India, Brazil, and several African nations hold significant potential due to growing healthcare investments and research infrastructure. Effective capitalization on these opportunities requires supportive funding, robust policy frameworks, increased public awareness, and enhanced international collaborations. Anticipated advancements include digital biobank platforms, AI-driven predictive models, and next-generation sequencing technologies, with a focus on international resource pooling. Recent events impacting the industry include the COVID-19 pandemic, which underscored biobanks' importance, high-profile data breaches leading to stricter regulations, and technological partnerships enhancing data management.

Biobanks Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Biobanks Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increase in incidence of chronic disease
    • Rising awareness about biobanks
    • Increasing population coupled with presence of a large geriatric population base
  • Market Restraints
    • Ethical and legal issues related to biobanking
  • Market Opportunities
    • Growing genomic research activities in economies
    • Increasing public awareness about genomic testing and stem cell therapies
  • Market Challenges
    • Long-Term Sustainability of Biobanks
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Biobanks Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Biobanks Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Biobanks Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Biobanks Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Biobanks Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Biobanks Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Biobanks Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Biobanks Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Biobanks Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Biobanks Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

Before incorporating the Biobanks Market Research Report published by 360iResearch, we struggled with understanding the increasing incidence of chronic diseases. The report offered invaluable insights and actionable strategies that precisely addressed our challenges. For instance, the detailed analysis of market trends enabled us to optimize our research focus areas, significantly enhancing operational efficiency and research outcomes. We are thoroughly satisfied with how this report has positively influenced our organization's performance.
Artizan Biosciences, Inc.
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biobanks Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biobanks Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biobanks Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Before leveraging the Biobanks Market Research Report published by 360iResearch, we faced significant challenges in increasing public awareness about genomic testing and stem cell therapies. The report provided invaluable insights and actionable strategies that profoundly impacted our approach. We were able to implement targeted awareness campaigns and enhance our outreach initiatives, resulting in a 30% increase in participation. The comprehensive data and thorough analysis have been instrumental in shaping our strategies. Overall, we are extremely satisfied with the positive impact this report has had on our operations.
Shanghai Zhangjiang Biobank
To learn more about this report, request a free PDF copy
Key Company Profiles

The report delves into recent significant developments in the Biobanks Market, highlighting leading vendors and their innovative profiles. These include Artizan Biosciences, Inc., Shanghai Zhangjiang Biobank, Acorn Biolabs, Inc., Merck KGaA, Beckman Coulter, Inc. by Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, UK Biobank Limited, Bay Biosciences LLC, Provia Laboratories, LLC, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, Taylor-Wharton, Tecan Trading AG, and ProteoGenex, Inc..

Biobanks Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Consumables
    • Equipment
    • Services
    • Software
  • Sample Type
    • Biological Fluids
    • Blood Products
    • Cell Lines
    • Human Tissues
    • Nucleic Acids
  • Application
    • Clinical Research
    • Life Science Research
    • Regenerative Medicine

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

As a leading player in the genomic research field, Acorn Biolabs, Inc. was grappling with the complexities of market trends and resource allocation. The Biobanks Market Research Report by 360iResearch delivered invaluable insights that transformed our decision-making process. From navigating the competitive landscape to identifying growth opportunities, the actionable strategies have been a game-changer. One notable benefit was refining our targeting efforts in emerging economies, which significantly boosted our engagement and project success rates. We're highly satisfied with the positive impact on our operations and look forward to leveraging more insights from 360iResearch in the future.
Acorn Biolabs, Inc.
To learn more about this report, request a free PDF copy
This research report offers invaluable insights into various crucial aspects of the Biobanks Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Biobanks Market, by Component
  7. Biobanks Market, by Sample Type
  8. Biobanks Market, by Application
  9. Americas Biobanks Market
  10. Asia-Pacific Biobanks Market
  11. Europe, Middle East & Africa Biobanks Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 292]
  16. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the Biobanks Market?
    Ans. The Global Biobanks Market size was estimated at USD 67.81 billion in 2023 and expected to reach USD 75.75 billion in 2024.
  2. What is the Biobanks Market growth?
    Ans. The Global Biobanks Market to grow USD 148.10 billion by 2030, at a CAGR of 11.80%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.